Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Marjaneh, Mahdi Moradi ^a,b   Kirk, Edwin P ^b,c   Posch, Maximilian G ^d,e   Ozcelik, Cemil ^d   Berger, Felix ^e   Hetzer, Roland ^e   Otway, Robyn ^a   Butler, Tanya L ^f,g   Blue, Gillian M ^f   Griffiths, Lyn R ^h   Fatkin, Diane ^a,b,i   Martinson, Jeremy J ^j   Winlaw, David S ^f,g   Feneley, Michael P ^a,b,i   Harvey, Richard P ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^f CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h GRIFFITH UNIVERSITY   (Australia)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 4;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CAUCASIAN; CHILD; CONTROLLED STUDY; CRYPTOGENIC STROKE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART ATRIUM SEPTUM DEFECT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PATENT FORAMEN OVALE; PATIENT SELECTION; PRESCHOOL CHILD; SCHOOL CHILD; STROKE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FORAMEN OVALE, PATENT; GATA4 TRANSCRIPTION FACTOR; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYOCARDIUM; POLYMORPHISM, GENETIC; STROKE; YOUNG ADULT;

EID: 79958138045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020711     Document Type: Article

References (67)

1. Centers for Disease Control and Prevention (2007) WISQARS Leading Causes of Death Reports, 1999-2006. Available: http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html via the Internet. Accessed 27 April 2010.
2. Centers for Disease Control and Prevention (2001) Morbidity and Mortality Weekly Report (MMWR), 2001. 50: 120-125.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121 (7): 948-954.
4. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, (2002) Effect of medical treatment in stroke patients with patent foramen ovale. Circulation 105: 2625-2631.
5. Musolino R, La Spina P, Granata A, Gallitto G, Leggiadro N, et al. (2003) Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 15 (1-2): 121-128.
6. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, et al. (2003) Frequency and mechanism of stroke recurrence after cryptogenic stroke. Ann Neurol 54: 227-234.
7. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, et al. (1989) Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 25 (4): 382-390.
8. Di Tullio MR, Homma S, (2002) Mechanisms of cardioembolic stroke. Curr Cardiol Rep 4: 141-148.
9. Lechat P, Mas JL, Lascault G, Loron P, Theard M, et al. (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (18): 1148-1152.
10. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S, (1992) Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 117 (6): 461-465.
11. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, et al. (1993) Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 24 (1): 31-34.
12. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, et al. (2002) Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 33 (3): 706-711.
13. Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, et al. (1996) Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 77: 1202-1209.
14. Hagen PT, Scholz DG, Edwards WD, (1984) Incidence and size of patent foramen ovale during the first 10 decades: An autopsy study of 965 normal hearts. Mayo Clin Proc 59: 17-20.
15. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, et al. (1992) Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 86: 1902-1908.
16. Schuchlenz HW, Weihs W, Horner S, Quehenberger F, (2000) The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 109: 456-462.
17. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, et al. (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31 (10): 2407-2413.
18. Aslam F, Shirani J, Haque AA, (2006) Patent foramen ovale: assessment, clinical significance and therapeutic options. South Med J 99 (12): 1367-1372.
19. Ferrarini G, Malferrari G, Zucco R, Gaddi O, Norina M, et al. (2005) High prevalence of patent foramen ovale in migraine with aura. J Headache Pain 6 (2): 71-76.
20. Dalla VG, Guindani M, Zavarise P, Griffini S, Pezzini A, et al. (2005) Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 6: 328-330.
21. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG, (1999) Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 52: 1622-1625.
22. Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, et al. (2003) Patent foramen ovale with paradoxical embolism: midterm results of transcatheter closure in 256 patients. J Interv Cardiol 16: 43-50.
23. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, et al. (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62 (8): 1399-1401.
24. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, et al. (2010) Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation 121 (12): 1406-1412.
25. Schwerzmann M, Seiler C, Lipp E, Guzman R, Lövblad KO, et al. (2001) Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 134 (1): 21-24.
26. Wright DD, Gibson KD, Barclay J, Razumovsky A, Rush J, et al. (2010) High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins. J Vasc Surg 51 (1): 104-107.
27. Kirk EP, Sunde M, Costa MW, Rankin SA, Wolstein O, et al. (2007) Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 81 (2): 280-291.
28. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL, (2004) Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 90: 1315-1320.
29. Arquizan C, Coste J, Touboul PJ, Mas JL, (2001) Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 32: 1563-1566.
30. Stennard FA, Costa MW, Lai D, Biben C, Furtado MB, et al. (2005) Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132 (10): 2451-2462.
31. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, et al. (2000) Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87 (10): 888-895.
32. Ng MYM, Andrew T, Spector TD, Jeffery S, (2005) Linkage to the FOXC2 region of chromosome 16 for varicose veins in the otherwise healthy, unselected sibling pairs. J Med Genet 42: 235-239.
33. Brickner ME, Hillis D, Lange RA, (2000) Medical progress: Congenital heart disease in adults (first of two parts). N Engl J Med 342: 256-263.
34. McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, et al. (2002) Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 87 (3): 256-259.
35. Balzer DT, (2004) Transcatheter Closure of Intracardiac Shunts. Curr Treat Options Cardiovasc Med 6 (5): 417-422.
36. McElhinney, Geiger E, Blinder J, Benson DW, Goldmutntz E, (2003) NKX2.5 mutations in patients with congenital heart diseases. J Am Coll Cardiol 42: 1650-1655.
37. Kasahara H, Benson DW, (2004) Biochemical analyses of eight NKX2-5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res 64: 40-51.
38. Reamon-Buettner SM, Hecker H, Spanel-Borowski K, Craatz S, Kuenzel E, et al. (2004) Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations. Am J Pathol 164: 2117-2125.
39. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, et al. (2005) Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 135: 47-52.
40. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, et al. (2005) Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42 (2): e16.
41. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, et al. (1998) Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
42. Srivastava D, Olson EN, (2000) A genetic blueprint for cardiac development. Nature 407: 221-226.
43. Kirk EP, Hyun C, Thomson PC, Lai D, Castro ML, et al. (2006) Quantitative trait loci modifying cardiac atrial septal morphology and risk of patent foramen ovale in the mouse. Circ Res 98 (5): 651-658.
44. Crispino JD, Lodish MB, Thurberg BL, Litovsky SH, Collins T, et al. (2001) Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 15 (7): 839-844.
45. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, et al. (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
46. Poirier O, Nicaud V, McDonagh T, Dargie HJ, Desnos M, et al. (2003) Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy. Eur J Hum Genet 11 (9): 659-664.
47. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, et al. (2001) Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes and Development 15: 2702-2719.
48. Morrisey EE, Ip HS, Tang Z, Parmacek MS, (1997) GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J Biol Chem 272: 8515-8524.
49. Schluterman MK, Krysiak AE, Kathiriya IS, Abate N, Chandalia M, et al. (2007) Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. Am J Med Genet A 143A (8): 817-823.
50. Sherin C, Francesca F, Karl P, Brendan T, Ron H, et al. (2008) Investigation between the S377G3 GATA-4 polymorphism and migraine. Open Neurol J 2: 35-38.
51. Martinson JJ, Hong L, Karanicolas R, Moore JP, Kostrikis LG, (2000) Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype. AIDS 14 (5): 483-489.
52. Chen X, Levine L, Kwok PY, (1999) Fluorescence polarization in homogeneous nucleic acid analysis. Genome Research 9: 492-498.
53. Posch MG, Perrot A, Schmitt K, Mittelhaus S, Esenwein EM, et al. (2008) Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A 146A (2): 251-253.
54. Cavalli-Sforza LL, Menozzi P, Piazza A, (1994) The history and geography of human genes Princeton, NJ Princeton University Press.
55. Feldt RH, Avasthey P, Yoshimasu F, Kurland LT, Titus JL, (1971) Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950-1969. Mayo Clin Proc 46 (12): 794-799.
56. Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, et al. (1985) Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6: 1370-1382.
57. Belkin RN, Waugh RA, Kisslo J, (1986) Interatrial shunting in atrial septal aneurysm. Am J Cardiol 57: 310-312.
58. Zabalgoitia-Reyes M, Herrera C, Ghandi DK, Mehlman DJ, McPherson DD, et al. (1990) A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm. Am J Cardiol 66: 761-764.
59. Molkentin JD, (2000) The zinc finger-containing transcription factors GATA-4,-5, and-6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275 (50): 38949-38952.
60. Charron F, Nemer M, (1999) GATA transcription factors and cardiac development. Semin Cell Dev Biol 10 (1): 85-91.
61. Laverriere AC, MacNeill C, Mueller C, Poelmann RE, Burch JB, et al. (1994) GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem 269 (37): 23177-23184.
62. Peterkin T, Gibson A, Loose M, Patient R, (2005) The roles of GATA-4,-5 and-6 in vertebrate heart development. Semin Cell Dev Biol 16 (1): 83-94.
63. Reamon-Buettner SM, Borlak J, (2005) GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J Med Genet 42 (5): e32.
64. Negi S, Singh SK, Pati N, Handa V, Chauhan R, et al. (2004) A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription. Biochem J 379 (Pt 1): 151-159.
65. Marcovina SM, Koschinsky ML, (1998) Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 82 (12A): 57U-66U.
66. Lippi G, Guidi G, (2003) Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 40 (1): 1-42.
67. Butler TL, Esposito G, Blue GM, Cole AD, Costa MW, et al. (2010) GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers 14 (6): 797-802.